DEB 2016_Preliminary Programme_2016_08_19
Transcription
DEB 2016_Preliminary Programme_2016_08_19
International 3rd DEB Symposium European Drug Eluting Balloon Consensus Group 14–15 October 2016 www.deb-symposium.de PROGRAMME Berlin © Sergey Nivens - 144482908/popmarleo - 86400313 - shutterstock.com Table of Contents Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System BROADEST SIZE MATRIX INCLUDING COMPLEXLV 4.5 5.0 mm AND THE MAIN SOLUTION Resolute Onyx™ DES now brings its advanced workhorse performance to left main stenting— providing the size, strength and conformability to help more patients heal. www.medtronicstents.com www.theadvancedworkhorse.com © 2016 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. For distribution only in markets where the Resolute Onyx™ coronary stent has been approved. Not for distribution in the USA, Japan or France. UC201606085ML-01 2/16 mm Table of Contents Organisation and Imprint .......................................................................................... 4 Welcome Note of the Symposium Chairs.................................................................. 5 General Information................................................................................................... 6 Sponsors and Exhibitors............................................................................................. 7 Scientific Programme Friday, 14 October 2016 .............................................................................. 8 Saturday, 15 October 2016 ......................................................................... 11 Index of Speakers, Discussants and Session Chairs................................................... 14 The 3rd International DEB Symposium is organised under the auspices of the: Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. Design and Layout Layout Print Circulation Editorial Deadline krea.tif-art UG (haftungsbeschränkt) www.xxx.de xx xx xx xxxx 3 Organisation and Imprint Venue Langenbeck-Virchow-Haus Luisenstraße 58 • 10117 Berlin (DE) Date 14–15 October 2016 Symposium Website www.deb-symposium.de Organiser European Drug Eluting Balloon Consensus Group Symposium Chairs Univ.-Prof. Dr. med. Franz X. Kleber Cardio Centrum Berlin Academic Teaching Institution Charité University Medicine Berlin (DE) Prof. Dr. med. Bruno Scheller Saarland University Medical Center Homburg (DE) Scientific Organising Committee Dr. Fernando Alfonso Hospital Universitario de La Princesa Madrid (ES) Univ.-Prof. Dr. med. Franz X. Kleber Charité University Medicine Berlin (DE) Bernardo Cortese A.O. Fatebenefratelli Hospital Milan Milan (IT) Prof. Dr. med. Bruno Scheller Saarland University Medical Center Homburg (DE) Dr. Simon Eccleshall Norfolk and Norwich University Hospital Norwich (GB) Prof. Dr. med. Gunnar Tepe RoMed Hospital Rosenheim Rosenheim (DE) Prof. Dr. Raban Jeger University Hospital of Basel Basel (CH) for the European Consensus Group on Drug Coated Balloons Symposium Organisation Conventus Congressmanagement & Marketing GmbH Marlen Schiller/Carl Haubold Carl-Pulfrich-Straße 1 • 07745 Jena (DE) Phone +49 3641 31 16-358/-276 • Fax +49 3641 31 16-243 deb-symposium@conventus.de • www.conventus.de 4 Welcome Note of the Symposium Chairs Dear Colleagues, interventional cardiology is an ever changing field. Having established modern drug eluting stents with biocompatibel or bioresorbable surface coating and bioresorbale scaffolds the field is rapidly moving forward challenging coronary artery disease with stentless angioplasty. In the 3rd International Symposium on Drug Coated Balloons we will discuss this field with most of the leading scientists and the leading clinical investigators in the field from all over the world. Our aim is establishing a worldwide consensus on indications and mode of application as well as to stimulate further research. All are invited for an active part in this field. We are most happy to welcome you. Berlin will host this event with an open atmosphere and a lively communication tradition. Franz Xaver Kleber Bruno Scheller 5 General Information Registration Registration for the symposium is free of charge. Please register online at www.deb-symposium.de. Opening Hours Check In/ Speakers Ready Room Industrial Exhibition Friday 12.00–20.00 Saturday 07.30–13.00 12.30–21.00 07.30–13.30 Education Credits and Certification … for attendants from Germany The symposium is certified by the Medical Chamber of Berlin as follows: 14 October 15 October 6 Points 6 Points Category B Category B For certification all attendants are required to sign the certification list near the registration daily. Certificates of attendance may be picked up upon leaving the symposium at the registration desk. … for European attendants The symposium is accredited by the European Board for Accreditation in Cardiology (EBAC) for 9 hours of external CME credits. Scientific Programme 14 October 2016 5 CME credits 15 October 2016 4 CME credits Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS). Catering and Lunch Tea, coffee, refreshments and snacks will be available free of charge during all programme breaks within the industrial exhibition area. Internet A wireless internet access (wifi) is available in the building. Detailed information you will receive at the registration desk. 6 Sponsors and Exhibitors Sponsors Gold Sponsor B.Braun Melsungen AG Vascular Systems Berlin Medtronic GmbH Meerbusch Silver Sponsor Further Sponsor Spectranetics Deutschland GmbH Würzburg Exhibitors B.Braun Melsungen AG Vascular Systems Berlin Boston Scientific Medizintechnik GmbH Ratingen Medtronic GmbH Meerbusch Spectranetics Würzburg State at printing 7 Scientific Programme • Friday, 14 October 2016 12.30–13.00 Coffee within the Industrial Exhibition 13.00–13.40Introduction Room Plenary Hall Chair Ran Kornowski (Petah Tikva/IR) 13.00 Opening Franz X. Kleber (Berlin/DE), Bruno Scheller (Homburg/DE) 13.10 Quo vadis PCI Ran Kornowski (Petah Tikva/IR) 13.25 History of drug coated balloon development Ulrich Speck (Berlin/DE) 13.40–15.13 Room Chairs Co-Chair Discussants Session 1: The current state of DCB-PCI 1 – ISR Plenary Hall Fernando Alfonso (Madrid/ES), Bruno Scheller (Homburg/DE) Amin Ariff Nuruddin (Kuala Lumpur/MY) Harald Rittger (Fürth/DE), Bernardo Cortese (Milan/IT) 13.40 In stent restenosis – state of the art Fernando Alfonso (Madrid/ES) 13.53 DES ISR round table discussion: … stent is superior – Fernando Alfonso (Madrid/ES) … DCB is superior – Bruno Scheller (Homburg/DE) … DCB is equal – Robert A. Byrne (Munich/DE) 14.23 In stent restenosis – TLR in ISAR Desire and RIBS revisited Bruno Scheller (Homburg/DE) 14.36 In stent restenosis – Japanese experience Seiji Habara (Kurashiki/JP) 14.49 Neoatherosclerosis Robert A. Byrne (Munich/DE) 15.01 Long term follow – Mortality benefit in ISR? Harald Rittger (Fürth/DE) 8 Scientific Programme • Friday, 14 October 2016 15.13–16.01 Room Chairs Discussants Session 2: The current state of DCB-PCI 2 – de novo Plenary Hall Azeem Latib (Milan/IT), Bernardo Cortese (Milan/IT) Simon Eccleshall (Norwich/GB), Eun-Seok Shin (Ulsan/KR) 15.13 De novo – state of the art Raban Jeger (Basel/CH) 15.25 De novo – In small vessels only? Franz X. Kleber (Berlin/DE) 15.37 De novo – Bifurcations Kenneth Chin (Kuala Lumpur/ MY) 15.49 De novo – What kind of proof do we need before we really use this therapy in de novo Azeem Latib (Milan/IT) 16.01–16.25 Room Coffe Break within the Industrial Exhibition Foyer 16.25–17.25 Room Chairs Discussants Session 3: New studies, new indications 1 – de novo Plenary Hall Raban Jeger (Basel/CH), Simon Eccleshall (Norwich/GB) Robert A. Byrne (Munich/DE), Piotr P. Buszman (Ustrom/PL) 16.25 DEB in patients with a high bleeding risk – registry study and DEBUT RCT Tuomas Rissanen (Joensuu/FI) 16.37 Japanese SVD study Atsushi Funatsu (Kyoto/JP) 16.49 Leipzig Data Madlen Uhlemann (Leipzig/DE) 17.01 All comers registry on 1025 pts Mark Rosenberg (Kiel/DE) 17.13 International bifurcation registry Leonhard Bruch (Berlin/DE) 9 Scientific Programme • Friday, 14 October 2016 17.25–18.13 Room Chairs Discussants Session 4: Technical aspects 1 Plenary Hall Wan Azman Wan Ahmad (Kuala Lumpur/MY) Franz X. Kleber (Berlin/DE) Mark Rosenberg (Kiel/DE), Bernardo Cortese (Milan/IT) 17.25 Predilatation and lesion preparation with scoring/cutting balloons Robert A. Byrne (Munich/DE) 17.37 Dissection is what we need or what we fear? Bernardo Cortese (Milan/IT) 17.49 Strategies to reduce the impact of dissection and recoil Bruno Scheller (Homburg/DE) 18.01 The value of FFR measurement for the DCB decision Eun-Seok Shin (Ulsan/KR) 18.13–19.05 Room Chairs Discussants Session 5: Clinical and pathophysiological aspects Plenary Hall Bruno Scheller (Homburg/DE), Simon Eccleshall (Norwich/GB) Wan Azman Wan Ahmad (Kuala Lumpur/MY) Leonhard Bruch (Berlin/DE) 18.13 Importance of pharmocokinetics for clinical efficacy Bruno Scheller (Homburg/DE) 18.26 Combination of DCB with DES and BVS Azeem Latib (Milan/IT) 18.39 Vascular restoration 1 – vascular remodeling and healing Tudor-Constantin Pörner (Jena/DE) 18.52 Vascular restoration 2 – plaque regression and redistribution Eun-Seok Shin (Ulsan/KR) 20.00 Room Get-Together Foyer 10 Scientific Programme • Saturday, 15 October 2016 08.00–08.25Morning coffee within the Industrial Exhibition Room Foyer 08.30–09.40 Room Chairs Discussants Session 6: New studies, new indications 2 Plenary Hall Ulf Landmesser (Berlin/DE), Junbo Ge (Shanghai/CN) Tuomas Rissanen (Joensuu/FI), Robert A. Byrne (Munich/DE) 08.30 New indications confirmed 2 – ACS and acute MI Hee Hwa Ho (Singapure/SG) 08.45 DCB for CTO – New paradigm? Houng Bang Liew (Kota Kinabalu/MY) 09.00 Mortality benefit – round table with discussion ... Introduction (Stent Thrombosis, Stent in Stent Thrombosis, TVR with stents for de novo and ISR) – Simon Eccleshall (Norwich/GB) ... PEPCAD DES – Harald Rittger (Fürth/DE) ... PEPCAD China – Junbo Ge (Shanghai/CH) ... ISAR Desire III – Robert A. Byrne (Munich/DE) ... BELLO – Francesco Giannini (Milan/IT) 09.40–10.25 Room Chairs Discussants Session 7: Technical aspects 2 Plenary Hall Bruno Scheller (Homburg/DE), Franz X. Kleber (Berlin/DE) Wan Azman Wan Ahmad (Kuala Lumpur/MY) Mark Rosenberg (Kiel/DE) 09.40 Is there a geographic mismatch problem in de novo? Bernardo Cortese (Milan/IT) 09.55 Is there an optimal luminal gain in de novo? Atsushi Funatsu (Kyoto/JP) 10.10 Do large vessels respond any different? Simon Eccleshall (Norwich/GB) 10.25–10.55 Room Coffee Break within the Industrial Exhibition Foyer 11 Scientific Programme • Saturday, 15 October 2016 10.55 – 12.10 Room Chairs Discussants Session 8: Peripheral application Plenary Hall Gunnar Tepe (Rosenheim/DE), Francesco Liistro (Arzzo/IT) Marianne Brodmann (Graz/AT) Michael Werk (Berlin/DE) Thomas Zeller (Bad Krozingen/DE 10.55 Epidemiology of and challenges in peripheral arterial disease N.N. 11.10 DCB new standard of care in the SFA? Michael Werk (Berlin/DE) 11.22 Calcified lesions – the role of vessel preparation Gunnar Tepe (Rosenheim/DE) 11.34 BTK – reasons for DCB failure Marianne Brodmann (Graz/AT) 11.46 DCB work in BTK – if you select the right patients and take care of their wounds Francesco Liistro (Arzzo/IT) 11.58 Unmet needs in peripheral interventions – future role of DCB or other technologies Thomas Zeller (Bad Krozingen/DE) 12.10 – 13.00 Room Chairs Discussants Session 9: A glance into the future Plenary Hall Piotr P. Buszman (Ustrom/PL), Thomas Zeller (Bad Krozingen/DE) Kenneth Chin (Kuala Lumpur/ MY) 12.10 DCB in a pediatric population Hashim Abdul-Khaliq (Homburg/DE) 12.20 Sirolimus eluting DCBs, first experiences Bruno Scheller (Homburg/DE) 12 Scientific Programme • Saturday, 15 October 2016 12.30 New carriers and new drugs Ulrich Speck (Berlin/DE) 12.40 Statements of Chinese, Italian and Japanese consensus groups Bernardo Cortese (Milan/IT) Atsushi Funatsu (Kyoto/JP) Junbo Ge (Shanghai/CN) 12.55 Adjourn, summary and publication strategy Franz X. Kleber (Berlin/DE) 13.00 Room Soup and Refreshments within the Industrial Exhibition Foyer Did you know? Conventus is the Professional Congress Organiser for the 3rd International DEB Symposium* *European Drug Eluting Balloon Consensus Group 13 Index of speakers, discussants and session chairs A Hashim Abdul-Khaliq (Homburg/DE) Fernando Alfonso (Madrid/ES) B Marianne Brodmann (Graz/AT) Leonhard Bruch (Berlin/DE) Piotr P. Buszman (Ustrom/PL) Robert A. Byrne (München/DE) 12 8 12 9, 10 9, 12 8, 9 10, 11 C Kenneth Chin (Kuala Lumpur/MY) 9, 12 Bernardo Cortese (Milan/IT) 8, 9, 10, 11, 13 E Simon Eccleshall (Norwich/GB) 9, 10, 11 F Atsushi Funatsu (Kyoto/JP) G Junbo Ge (Shanghai/CH) Francesco Giannini (Milan/IT) H Seiji Habara (Kurashiki/JP) Hee Hwa Ho (Singapore/SG) J Raban Jeger (Basel/CH) 9, 11, 13 11, 13 11 8 11 9 K Franz X. Kleber (Berlin/DE) 8, 9, 10, 11, 13 Ran Kornowski (Hasharon /IR) 8 14 L Uwe Landmesser (Berlin/DE) 11 Azeem Latib (Milan/IT) 9, 10 Houng Bang Liew (Kota Kinabalu/MY) 11 Francesco Liistro (Arezzo/IT) 12 N Amin Ariff Nuruddin (Kuala Lumpur/MY)8 P Tudor-Constantin Pörner (Jena/DE) 10 R Tuomas Rissanen (Joensuu/FI) Harald Rittger (Fürth/DE) Mark Rosenberg (Kiel/DE) 9, 11 8, 11 9, 10, 11 S Bruno Scheller (Homburg/DE) Eun-Seok Shin (Ulsan/KR) Ulrich Speck (Berlin/DE) 8, 10 11, 12 9, 10 8, 13 T Gunnar Tepe (Rosenheim/DE) 12 U Madlen Uhlemann (Leipzig/DE) 9 W Wan Azman Wan Ahmad (Kuala Lumpur/MY) Michael Werk (Berlin/DE) Z Thomas Zeller (Bad Krozingen/DE) 10, 11 12 12 One Device. Two Technologies. One Device. Two Technologies. AngioSculpt®X catheter is the only device you need for both plaque scorin ne The Device. Two Technologies. in challenging coronary casesyou such asfor ISR.both plaque scoring and drug delivery AngioSculpt®X catheter is the only device need The AngioSculpt®X catheter is the only device you need for both plaque scoring hallenging coronary cases such as ISR. and drug delivery in challenging coronary cases such as ISR. Visit us at booth n.34 us atn.34 booth n.3 sit us atVisit booth ©2016 Spectranetics. All rights reserved. Approved for external distribution in EU only. AngioSculptX is not approved for distribution in the US. D031426-00 092016 anetics. All rights reserved. Approved for external distribution in EU only. AngioSculptX is not approved for distribution in the US. D031426-00 092016 ©2016 Spectranetics. All rights reserved. Approved for external distribution in EU only. AngioSculptX is not approved for distribution in the US. D031426-00 092016 B.Braun Anzeige Interventional Vascular Diagnostics and Therapy YOUR SOLUTION-ORIENTED PRODUCT CONCEPT FOR A POLYMER-FREE ANGIOPLASTY A-VS16004 B. Braun Melsungen AG | Vascular Systems | Sieversufer 8 | 12359 Berlin Phone +49 30 568 207-300 | vascular.systems@bbraun.de | www.bbraun.de
Similar documents
program of the event |
adhesion molecules (sVCAM-1) in patients treated with percutaneous balloon dilatation with stent implantation, and patients treated with paclitaxelcoated balloon
More information